A hauberk is a shirt of mail. The term is usually used to describe a shirt reaching at least to mid-thigh and including sleeves. Haubergeon (little hauberk) generally refers to a smaller version of the hauberk, but the terms are often used interchangeably.
A REMS (Risk Evaluation and Mitigation Strategy) is a program required by the Food and Drug Administration to manage known or potential serious risks associated with a drug product. The purpose of the ProliaÂ® REMS is to inform healthcare providers and patients about the following serious risks of: Hypocalcemia.
As of 2017, eleven disease-modifying medications have been approved by regulatory agencies for relapsing-remitting multiple sclerosis (RRMS). They are interferon beta-1a, interferon beta-1b, glatiramer acetate, mitoxantrone, natalizumab, fingolimod, teriflunomide, dimethyl fumarate, alemtuzumab, daclizumab, and ocrelizumab.